Who Owns CNS Pharmaceuticals Stock?
NASDAQ: CNSPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 4:00 PM ET
Ownership breakdown
- Held by institutions
- 21.25%
- Held by insiders
- 0.95%
- Institutional holders
- 13
- Institutions 21.3%
- Insiders 0.9%
- Public and other 77.8%
Who owns CNS Pharmaceuticals stock?
Institutional investors own about 21.3% of CNS Pharmaceuticals's shares, spread across 13 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.95% of CNSP.
The largest institutional holders are Ikarian Capital, LLC (9.29%), Adar1 Capital Management, LLC (4.79%) and Stonepine Capital Management, LLC (2.84%). Together, the top 10 institutions control 19.2% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their CNSP positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CNSP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Ikarian Capital, LLC | 135.83K | 9.29% | +196.4% |
| Adar1 Capital Management, LLC | 70.00K | 4.79% | +100.0% |
| Stonepine Capital Management, LLC | 41.57K | 2.84% | -31.9% |
| Boothbay Fund Management, LLC | 13.52K | 0.93% | 0.0% |
| Vanguard Fiduciary Trust Co | 10.23K | 0.70% | +100.0% |
| Vanguard Capital Management LLC | 6.99K | 0.48% | +100.0% |
| UBS Group AG | 1.46K | 0.10% | +100.4% |
| Tower Research Capital LLC (TRC) | 799 | 0.05% | -39.0% |
| Barclays Plc | 19 | 0.00% | +100.0% |
| Barrett & Company, Inc. | 8 | 0.00% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CNSP
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 8.32K | 0.57% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 6.99K | 0.48% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 555 | 0.04% |
Frequently asked questions
Who is the largest shareholder of CNS Pharmaceuticals?
Ikarian Capital, LLC is the largest institutional shareholder of CNSP, owning 9.29% of shares outstanding (135.83K shares) as of its latest 13F filing.
What percentage of CNS Pharmaceuticals is owned by institutions?
Institutions own about 21.3% of CNSP shares and 21.5% of the public float.
How much of CNS Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.95% of CNSP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.